logga

Board

  • Patrik

    Patrik Holmqvist

    Head of Enterprise Architecture at Alfa Laval IT and Process director at Medicon Village. Engineer educated at LTH in Lund with broad experience within Information Sciences, general management and continuous improvement projects at AstraZeneca R&D.
  • karin

    Karin von Wachenfeldt

    CEO and cofounder of Truly Translational Sweden AB. Ph. D. In Immunotechnology from Lund University and Marketing Economist (EFL). Broad experience of early stage pharmaceutical development of small molecules and biopharmaceuticals from BioInvent, Pharmacia Upjohn, Active Biotech and AstraZeneca.
  • charlott

    Charlott Brunmark

    CSO and cofounder of Truly Translational Sweden AB. Ph. D. In Medical Sciences from Lund University. Broad experience within In vivo pharmacology and pharmaceutical development of small molecules as well as biologics from Pharmacia Upjohn, Active Biotech, Cartela and AstraZeneca.

©  Truly Translational Sweden AB   |   Org nr 556860-1123   |   Medicon Village, 223 81 Lund   |   +46 46 460 21 00   |    info@trulytranslational.com